t A.B. 1982, Brown University; M.A. 1988, Wesleyan University; J.D. Candidate 1991, University of Pennsylvania. This Comment is dedicated to my family, in appreciation for their support and encouragement, and to my former colleagues in the pharmaceutical industry who remain undaunted by the obstacles. I am grateful to Scott Burris for his comments on earlier drafts of this manuscript. Acquired Immune Deficiency Syndrome (AIDS) is a communicable and sexually transmitted disease caused by the human immuno-deficiency virus (HIV). It is the final phase in a continuum characterized by four distinct disease stages: first, an initial infection which often mimics mononucleosis; second, a period of latent, asymptomatic infection; third, persistent, regionalized lymph node enlargement sometimes called AIDS-related Complex (ARC); and finally, the multiple opportunistic infections, neurological impairments, and other clinical presentations that constitute AIDS. See Centers for Disease Control, U.S. Dep't of Health & Human Servs., Classification System for Human T-Lymphotrophic Virus Type III/LymphadenopathyAssociated Virus Infection, 105 ANNALS INTERNAL MED. 234, 234-35 (1986). The HIV virus is a retrovirus; it uses an enzyme called reverse transcriptase to introduce its genetic material (ribonucleic acid, or RNA) into the genetic material (deoxyribonucleic acid, or DNA) of a host cell. Initially, the virus is virtually undetectable. Seropositivity (the appearance of viral antibody in the serum) occurs when the altered host cell is properly stimulated by antigens. At that point, the infected host cell's replicatory machinery sees both the foreign viral material, as well as its own cellular DNA, and thus produces infected cells. Viral proteins are then synthesized and are subsequently packaged together witlh viral genome and released, going on to attack additional cells. HIV has a predilection for particular host cell types, namely, T-helper lymphocytes (also called T-4 cells), macrophages, and monocytes. Since the T-helper lymphocytes are responsible for cell-mediated immunity, their destruction by the virus is a critical cellular event in the development of the disease, causing the immunodeficiency which gives AIDS its name. See Fauci, Temin & Martin, The Scientific Agenda for AIDS, ISSUES SCI. & TECH., Winter 1988, at 33, 33-35; Mayer, The Clinical Challenges of AIDS and HIV Infection, 14 LAW, MED. & HEALTH CARE 281 (1986); Schild & Minor, Human Immunodeficieney Virus and AIDS: Challenges and Progress, 335 LANCET 1081, 1081-82 (1990). 2 For example, Larry Kramner is the founder of the AIDS Coalition to Unleash